Institutional Ownership Protalix Bio Therapeutics, Inc. (PLX)
This table provides information about the institutional ownership of Protalix Bio Therapeutics, Inc. (PLX). We have compiled data on the 67 institutions that hold shares in the stock, with a total of 8.7 Million shares, which have been reported (via 13F filing form) to have a value of $14.3 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
1,615,003
shares
|
$2.65 Million
0.0% of portfolio
|
Q2 2025
Added 35.83%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
1,079,723
shares
|
$1.77 Million
0.0% of portfolio
|
Q2 2025
Added 57.68%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
826,333
shares
|
$1.36 Million
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Aug 07, 2025 Q2 2025 |
496,216
shares
|
$813,794
0.0% of portfolio
|
Q2 2025
Added 2.76%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
484,798
shares
|
$795,068
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
462,043
shares
|
$757,750
0.0% of portfolio
|
Q2 2025
Added 452.96%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
444,239
shares
|
$728,551
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Stratos Wealth Partners, Ltd.
|
Jul 29, 2025 Q2 2025 |
350,000
shares
|
$574,000
0.01% of portfolio
|
Q2 2025
Added 1.04%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
333,171
shares
|
$546,400
0.0% of portfolio
|
Q2 2024
Reduced 89.94%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
298,567
shares
|
$489,649
0.0% of portfolio
|
Q2 2025
Reduced 65.23%
|
|
|
Commonwealth Equity Services, LLC
|
Aug 06, 2025 Q2 2025 |
196,797
shares
|
$322,747
0.0% of portfolio
|
Q2 2025
Added 293.4%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Aug 14, 2025 Q2 2025 |
189,100
shares
|
$310,124
0.01% of portfolio
|
Q1 2025
Added 4.24%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
175,070
shares
|
$287,114
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Evergreen Capital Management LLC
Bellevue, WA |
Aug 14, 2025 Q2 2025 |
171,338
shares
|
$280,994
0.01% of portfolio
|
Q2 2025
New holding
|
|
|
Diametric Capital, LP
Boston, MA |
Aug 13, 2025 Q2 2025 |
143,272
shares
|
$234,966
0.14% of portfolio
|
Q2 2025
New holding
|
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
126,963
shares
|
$208,219
0.0% of portfolio
|
Q2 2025
Added 422.27%
|
|
|
Hillsdale Investment Management Inc.
Toronto, A6 |
May 09, 2025 Q1 2025 |
116,100
shares
|
$190,404
0.02% of portfolio
|
Q1 2025
New holding
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
102,178
shares
|
$167,571
0.0% of portfolio
|
Q2 2025
Reduced 64.7%
|
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
90,188
shares
|
$147,908
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
75,150
shares
|
$123,245
0.0% of portfolio
|
Q2 2025
Added 3500.86%
|
|
|
Xtx Topco LTD
London, X0 |
Aug 12, 2025 Q2 2025 |
73,675
shares
|
$120,827
0.0% of portfolio
|
Q2 2025
Added 76.15%
|
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
71,537
shares
|
$117,320
0.0% of portfolio
|
Q2 2025
Reduced 17.16%
|
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
69,796
shares
|
$114,465
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
New York State Common Retirement Fund
|
Aug 13, 2025 Q2 2025 |
69,000
shares
|
$113,160
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Orin Green Financial, LLC
|
Jul 29, 2025 Q2 2025 |
61,200
shares
|
$100,368
0.04% of portfolio
|
Q2 2025
Added 22.4%
|